Elevance will leave D.C. this summer and is considering other markets to depart, executives said. The company outperformed Wall Street expectations in the second quarter — but not by much, and its stock fell accordingly.
Elevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2